# DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

> **NCT06388421** · — · RECRUITING · sponsor: **United Therapeutics** · enrollment: 900 (estimated)

## Conditions studied

- Pulmonary Hypertension Due to Lung Diseases and Hypoxia
- Pulmonary Hypertension
- Interstitial Lung Disease

## Interventions

- **OTHER:** Prospective study assessments

## Key facts

- **NCT ID:** NCT06388421
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-23
- **Primary completion:** 2030-09-01
- **Final completion:** 2030-11-30
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06388421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06388421, "DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06388421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*